52 Week Range
As of on the Bolsa de Valores do Estado de Sao Paulo ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Raia Drogasil SA announces own capital interest payment
Raia Drogasil SA reviews store opening guidance
Raia Drogasil SA completes acquisition of majority stake in 4-Bio Medicamentos SA
Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.
Av. Corifeu de Azevedo Marques
Antonio Carlos Pipponzi
Chairman of the Board
Marcilio D'Amico Pousada
Chief Executive Officer, Member of the Executive Board
Antonio Carlos Coelho
Chief Financial Officer, Member of the Executive Board
Fernando Kozel Varela
Chief of Technology, Supply Chain and Omnichannel
Marcello de Zagottis
Chief Marketing, Sales and Commercial Officer, Member of the Executive Board
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Brazil's largest pharmacy chain Raia Drogasil SA said on Tuesday it would fully acquire Drogaria Onofre, a rival controlled by CVS Health Corp.
Raia Drogasil SA, Brazil's largest drugstore chain, reported a fourth-quarter profit on Thursday that was in line with analysts' forecasts, as the company accelerated expansion amid Brazil's economy recovery.
Raia Drogasil SA, Brazil's largest drugstore chain, is opening new stores in three states on Brazil's northern coast, marking the end of its foray into new markets for now, but its investment cycle will continue, a top executive told Reuters on Monday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.